Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 22, 2009
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled releaseChi-Un Pae, Prakash S Masand, David M Marks, et al.Drug and Alcohol Dependence|February 24, 2012
Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategyTong H Lee, Steven T Szabo, J Corey Fowler, et al.The American Journal on Addictions|April 5, 2020
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition RegimensSandra D Comer, Paolo Mannelli, Danesh Alam, et al.European Journal of Pharmacology|April 6, 2007
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawalColin Davidson, Rupa Gopalan, Cassandra Ahn, et al.Clinical Neuropharmacology|June 11, 2009
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trialChi-Un Pae, David M Marks, Prakash S Masand, et al.Current Addiction Reports|March 29, 2021
Review of Popularity and Quality Standards of Opioid-Related Smartphone AppsRoger Vilardaga, Tykira Fisher, Paige E Palenski, et al.Drug and Alcohol Dependence|April 21, 2018
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trialAdam Bisaga, Paolo Mannelli, Miao Yu, et al.Addiction (Abingdon, England)|January 11, 2021
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials NetworkLi-Tzy Wu, William S John, Udi E Ghitza, et al.Psychiatric Genetics|November 30, 2005
A functional prodynorphin promoter polymorphism and opioid dependenceRiju Ray, Glenn A Doyle, James J Crowley, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 24, 2004
Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependenceRachel J Smith, Glenn A Doyle, Angela M Han, et al.Pageof 8